January 18, 2021 Monday, 18:05 Hrs
 Home |   IFCI Group  |   About Us  |   Our Network  |   Contact Us  |   Career
SENSEX  48,564.27  -470.40 
Home   IPO    New Listing   
In detail view of the listed IPO stocks and their date of listing, high, low, last price along with their volume.
IPO Synopsis
Gland Pharma Ltd
Registered Office: Sy No 143-148 150&151 Nr Gandi,X Roads D P Pally Dundigal, Hyderabad - 500043, Telangana, India.
Phone : 91-40-3051 0999   Fax:
Email :  investors@glandpharma.com  
Website :  www.glandpharma.com
Initial public offer of 43196968 equity shares of face value of Re. 1 each ("equity shares") of Gland Pharma Limited ("Company" or "Issuer") for cash at a price of Rs.1500 Per equity share (including a share premium of Rs.1499 per equity share) aggregating Rs.6479.55 crores (The "Offer") comprising a fresh issue of 8,333,333 equity shares aggregating up to Rs. 1250 crores on (The "fresh issue") and an offer for sale of 34,863,635 equity shares, including 19,368,686 equity shares by Fosun Pharma Industrial Pte. Ltd ("promoter selling shareholder") and 10,047,435 equity shares by Gland Celsus Bio Chemicals Private Limited, 3,573,014 equity shares By Empower Discretionary Trust, and 1,874,500 equity shares by Nilay Discretionary Trust (collectively, the "other selling shareholders" and collectively With the promoter selling shareholder are referred to as the "selling shareholders", and such equity shares, the "offered shares") aggregating up to Rs. 5229.55 crores (the "offer for sale"). The offer shall constitute 26.46% of the post-offer paid-up equity share capital of the company. The face value of Equity shares is Re.1 each. The offer price is Rs.1500 per equity share and is 1500 times the face value of the Equity Shares. The Anchor Investor Offer Price is Rs.1500 per Equity Share.
Issue Money Payable On
Opens On Closes On Application Allotment
09-Nov-20 11-Nov-20 1500.00-0.00 0.00-0.00
Minimum Application for shares in Nos : 10   Further Multiples of : 10
  (Rs) Lead Managers to the Issue
Project Cost 1250.00 Citigroup Global Markets India Pvt Ltd
Project Financed through Current Offer 6479.55  
Post Issue Equity Share Capital 163.28  
Issue Price 1500.00  
Funding incremental working capital requirements of the company Funding capital expenditure requirements of the company
General corporate purposes
Promoted By
Fosun Pharma Indust. Pte. Ltd
Shanghai Fosun Pharma. Group
Listing At
Registrar to the Issue
Link Intime India Pvt Ltd
New Listing
Company Listing Price(Rs)
Antony W... 436.10
Mrs Bect... 500.00
Burger K... 112.50
Search IPO
Open an Account
Online Trading
Become a